John (Jay) DalyClinical Study Risk Manager, Clinical Data Operations, Technology and Standards at UCB Biopharma
Over his career, Jay Daly has gained almost 20 years of experience in clinical monitoring, project management, quality assurance, and risk based monitoring. He has worked within the Biopharmaceutical and CRO environments in global trials, across multiple therapeutic areas and phases of product development. Jay joined the Risk Management and Data Quality Department at UCB as a Study Data Risk Manager in 2017 and transitioned into the role of a Risk Management Lead in 2019. He is responsible for facilitating risk assessment and planning activities, which include performing protocol complexity assessments, identifying critical data and processes, establishing quality tolerance limits, and managing the risk registry.